Inpharma Weekly

, Volume 941, Issue 1, pp 9–9 | Cite as

‘Protective’ apoE isoforms provide new lead in Alzheimer’s therapy

  • Theresa Szeto
Newsletter Article


The possibility of mimicking the effects of apolipoproteins E3 (apoE3) and E2 (apoE2) provides a new avenue of research in the hunt for novel treatments for Alzheimer’s disease (AD). In contrast to apoE4, apoE3 and apoE2 are considered to have protective effects with respect to some aspects of the pathogenesis of AD. Therapeutic implications arising from the role of apoE in AD were discussed by Dr Warren Strittmatter at the Third International Springfield Symposium on Advances in Alzheimer Therapy [ Illinois, US; May 1994 ].


APOE Gene Paired Helical Filament Neurofibrillary Degeneration Alzheimer Therapy Tangle Formation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 1994

Authors and Affiliations

  • Theresa Szeto

There are no affiliations available

Personalised recommendations